GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Expensive Performer
2880.3500 43.45 (1.53%)
NSE Mar 28, 2025 15:31 PM
Volume: 108.2K
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
05 Aug 2024
2880.35
1.53%
buy
by ICICI Securities Limited
Target: 2640 | Target met
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
 
GlaxoSmithKline Pharmaceuticals Ltd. is trading above all available SMAs
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - March 28, 2025
The Baseline | 28 Mar 2025, 05:07PM
Market closes lower, Jio Fin Serv invests Rs 1,000.2 crore in its subsidiary Jio Finance
Trendlyne Marketwatch | 28 Mar 2025, 04:05PM
Chart of the Week: Most new-age IT IPOs drop in valuations post listing
The Baseline | 27 Mar 2025